Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Technology
  • Clinical Studies
  • Investors
  • News
  • En
  • Français

Press Releases

Bone Therapeutics announces results of Annual General Meeting

  • Read more about Bone Therapeutics announces results of Annual General Meeting

Bone Therapeutics to participate in upcoming conferences

  • Read more about Bone Therapeutics to participate in upcoming conferences

Bone Therapeutics entre dans une nouvelle Phase de son développement Industriel

  • Read more about Bone Therapeutics entre dans une nouvelle Phase de son développement Industriel

Bone Therapeutics lève 9,5M €

  • Read more about Bone Therapeutics lève 9,5M €

Bone Therapeutics reçoit l'approbation des autorités et traite les premiers patients dans son étude clinique de phase III en ostéonécrose avec son produit PREOB®

  • Read more about Bone Therapeutics reçoit l'approbation des autorités et traite les premiers patients dans son étude clinique de phase III en ostéonécrose avec son produit PREOB®

Bone Therapeutics receives clearance for its pivotal phase III osteonecrosis trial with PREOB® in Europe and treats the first patients in the study

  • Read more about Bone Therapeutics receives clearance for its pivotal phase III osteonecrosis trial with PREOB® in Europe and treats the first patients in the study

Bone Therapeutics Raises €7.7 Million in Series D Fundraising

  • Read more about Bone Therapeutics Raises €7.7 Million in Series D Fundraising

Bone Therapeutics Invests in Cell Therapy Manufacturing Facility

  • Read more about Bone Therapeutics Invests in Cell Therapy Manufacturing Facility

Bone Therapeutics Awarded Manufacturing Authorisation and European Approval to Produce Allogeneic Bone Cell Therapy Products

  • Read more about Bone Therapeutics Awarded Manufacturing Authorisation and European Approval to Produce Allogeneic Bone Cell Therapy Products

Bone Therapeutics to Present at Upcoming Investor Conferences

  • Read more about Bone Therapeutics to Present at Upcoming Investor Conferences

Pagination

  • Previous page ‹‹
  • Next page ››
Subscribe to Press Releases
Wallonie Eu Flag

BioSenic SA
Rue Granbonpré 11 – Bâtiment H (bte 24)
1435 Mont-St-Guibert – Belgium
T.: +32 493 09 73 66
info@biosenic.com
Contact

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions